EW

#317
Edwards Lifesciences Corporation Common Stock
86.1 5 USD
-1.06%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
85.84
86.72
Intervallo Annuale
72.30
88.28
Variazione giornaliera
-1.06%
Variazione Mensile
+5.87%
Variazione di 6 mesi
-0.49%
Variazione Annuale
+11.26%
Chiusura Precedente
87.0 7
Open
85.9 7
Minimo
85.8 4
High
86.7 2
Volume
716
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 49.61 B
  • Employee 16 K
  • Founded N/A
  • CEO -
  • Website www.edwards.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRXP69
  • Industry Dispositivi Medicali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
46.58
Rapporto prezzo/fatturato
8.26

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

Notizie